Canlyniadau Chwilio - David Kavanagh

Mireinio'r Canlyniadau
  1. 1
    Genetics and complement in atypical HUS

    Genetics and complement in atypical HUS gan David Kavanagh, Tim Goodship

    Cyhoeddwyd 2010
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome

    Anticomplement C5 therapy with eculizumab for the treatment of paroxysmal nocturnal hemoglobinuria and atypical hemolytic uremic syndrome gan Edwin Wong, David Kavanagh

    Cyhoeddwyd 2014
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea

    Complement C5-inhibiting therapy for the thrombotic microangiopathies: accumulating evidence, but not a panacea gan Vicky Brocklebank, David Kavanagh

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Diseases of complement dysregulation—an overview

    Diseases of complement dysregulation—an overview gan Edwin Wong, David Kavanagh

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Diagnosis and treatment of thrombotic microangiopathy

    Diagnosis and treatment of thrombotic microangiopathy gan Gemma L. Thompson, David Kavanagh

    Cyhoeddwyd 2022
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Complement therapy in atypical haemolytic uraemic syndrome (aHUS)

    Complement therapy in atypical haemolytic uraemic syndrome (aHUS) gan Edwin Wong, Tim Goodship, David Kavanagh

    Cyhoeddwyd 2013
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Atypical haemolytic uraemic syndrome

    Atypical haemolytic uraemic syndrome gan David Kavanagh, Tim Goodship, Anna Richards

    Cyhoeddwyd 2006
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Atypical Hemolytic Uremic Syndrome, Genetic Basis, and Clinical Manifestations

    Atypical Hemolytic Uremic Syndrome, Genetic Basis, and Clinical Manifestations gan David Kavanagh, Timothy H.J. Goodship

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Atypical Hemolytic Uremic Syndrome

    Atypical Hemolytic Uremic Syndrome gan David Kavanagh, Tim Goodship, Anna Richards

    Cyhoeddwyd 2013
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Peritoneal dialysis-associated peritonitis in Scotland (1999-2002)

    Peritoneal dialysis-associated peritonitis in Scotland (1999-2002) gan David Kavanagh, Gordon Prescott, Robert Mactier

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Thrombotic Microangiopathy and the Kidney

    Thrombotic Microangiopathy and the Kidney gan Vicky Brocklebank, Katrina Wood, David Kavanagh

    Cyhoeddwyd 2017
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Complement and the prothrombotic state

    Complement and the prothrombotic state gan Christoph Q. Schmidt, Hubert Schrezenmeier, David Kavanagh

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Transplantation in Atypical Hemolytic Uremic Syndrome

    Transplantation in Atypical Hemolytic Uremic Syndrome gan David Kavanagh, Anna Richards, Tim Goodship, Hannu Jalanko

    Cyhoeddwyd 2010
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    A national specialized service in England for atypical haemolytic uraemic syndrome—the first year’s experience

    A national specialized service in England for atypical haemolytic uraemic syndrome—the first year’s experience gan Neil Sheerin, David Kavanagh, Timothy H.J. Goodship, Sally Johnson

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic

    Complement factor I: Regulatory nexus, driver of immunopathology, and therapeutic gan Thomas M Hallam, Stephen J. Sharp, Aikaterini Andreadi, David Kavanagh

    Cyhoeddwyd 2023
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Developments in anti-complement therapy; from disease to clinical trial

    Developments in anti-complement therapy; from disease to clinical trial gan Claire L. Harris, Richard B. Pouw, David Kavanagh, Ruyue Sun, Daniel Ricklin

    Cyhoeddwyd 2018
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    Advances in understanding of pathogenesis of aHUS and HELLP

    Advances in understanding of pathogenesis of aHUS and HELLP gan Celia J. Fang, Anna Richards, M. Kathryn Liszewski, David Kavanagh, John P. Atkinson

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Disease-associated N-terminal Complement Factor H Mutations Perturb Cofactor and Decay-accelerating Activities

    Disease-associated N-terminal Complement Factor H Mutations Perturb Cofactor and Decay-accelerating Activities gan Isabell Pechtl, David Kavanagh, Nicola McIntosh, Claire L. Harris, Paul N. Barlow

    Cyhoeddwyd 2011
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Structural basis for sialic acid–mediated self-recognition by complement factor H

    Structural basis for sialic acid–mediated self-recognition by complement factor H gan Bärbel S. Blaum, Jonathan P. Hannan, Andrew P. Herbert, David Kavanagh, Dušan Uhrı́n, Thilo Stehle

    Cyhoeddwyd 2014
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Factor B as a therapeutic target for the treatment of complement-mediated diseases

    Factor B as a therapeutic target for the treatment of complement-mediated diseases gan David Kavanagh, Jonathan Barratt, Anna Schubart, Nicholas J.A. Webb, Matthias Meier, Fádi Fakhouri

    Cyhoeddwyd 2025
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: